All In Biotech

Drug Trial Radar · NCT01281202

Vigabatrin for the Treatment of Cocaine Dependency

Vigabatrin for Treatment of Cocaine Dependence: A Phase II Study

Last checked: Nov 19, 2026Latest source record: May 18, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 207 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

207

Actual

Start

Jan 2011

Primary completion

Oct 2012

Study completion Dec 2012

Sponsor

Lead sponsor
Catalyst Pharmaceuticals, Inc.Industry
Sponsor type
Industry
Collaborators
National Institute on Drug Abuse (NIDA); VA Office of Research and Development
First posted
Jan 21, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this 26-28 week study is to demonstrate that the rate of cocaine dependent subjects treated with CPP-109 vigabatrin in addition to counseling, who completely stop use of cocaine in the last 2 weeks of the study's Treatment Phase (Weeks 8 and 9) will be higher than seen in subjects treated with placebo in addition to counseling.

Conditions

  • Cocaine Addiction
  • Cocaine Dependence

Interventions

  • VigabatrinDrug

    Tablets

  • Matching PlaceboDrug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AbstinenceTime frame: Weeks 8-9

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Matrix Institute on Addictions

    Los Angeles, California

  • Friends Research Institute

    Torrance, California

  • VA Medical Center

    Denver, Colorado

  • University of Miami School of Medicine

    Miami, Florida

  • NeuroPsychiatric Research & Practice Assoc., Ltd.

    Oak Brook, Illinois

  • Mountain Manor Treatment Center @ Baltimore

    Baltimore, Maryland

  • Boston University School of Medicine

    Boston, Massachusetts

  • Pacific Institute for Research and Evaluation

    Albuquerque, New Mexico

  • Western Psychiatric Inst. and Clinic

    Pittsburgh, Pennsylvania

  • Medical University of South Carolina

    Charleston, South Carolina

  • Pillar Clinical Research, LLC

    Dallas, Texas

  • University of Texas Health Science Center at Houston

    Houston, Texas

  • George E Wahlen VA Medical Center

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.